Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Sales | 10,791 | 11,432 | 9,621 | 7,396 | 10,252 |
| Gross Profit | 10,791 | 11,432 | 9,621 | 7,396 | 10,252 |
| Operating Expenses | 57,509 | 57,147 | 52,365 | 45,349 | 39,249 |
| Operating Income | -46,718 | -45,715 | -42,744 | -37,953 | -28,997 |
| Other Income | 1,009 | 314 | 211 | 295 | 39 |
| Pre-tax Income | -45,709 | -45,401 | -42,533 | -37,658 | -28,958 |
| Income Tax | N/A | N/A | N/A | 44 | -123 |
| Net Income Continuous | -45,709 | -45,401 | -42,533 | -37,702 | -28,835 |
| Net Income | $-45,709 | $-45,401 | $-42,533 | $-37,702 | $-28,835 |
| EPS Basic Total Ops | -0.90 | -1.01 | -0.95 | -0.85 | -0.65 |
| EPS Basic Continuous Ops | -0.90 | -1.01 | -0.95 | -0.85 | -0.65 |
| EPS Diluted Total Ops | -0.90 | -1.01 | -0.95 | -0.85 | -0.65 |
| EPS Diluted Continuous Ops | -0.90 | -1.01 | -0.95 | -0.85 | -0.65 |
| EBITDA(a) | $-43,749 | $-42,632 | $-39,949 | $-35,737 | $-26,855 |